Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2020 | Nov. 20, 2020 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2020 | |
Document Transition Report | false | |
Entity File Number | 001-33720 | |
Entity Registrant Name | Remark Holdings, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 33-1135689 | |
Entity Address, Address Line One | 800 S. Commerce St. | |
Entity Address, City or Town | Las Vegas | |
Entity Address, State or Province | NV | |
Entity Address, Postal Zip Code | 89106 | |
City Area Code | 702 | |
Local Phone Number | 701-9514 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Title of 12(b) Security | Common Stock, $0.001 par value per share | |
Trading Symbol | MARK | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 99,505,041 | |
Entity Central Index Key | 0001368365 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Assets | ||
Cash and cash equivalents | $ 2,090 | $ 272 |
Trade accounts receivable, net | 2,850 | 1,964 |
Inventory, net | 1,062 | 0 |
Prepaid expense and other current assets | 5,831 | 4,623 |
Total current assets | 11,833 | 6,859 |
Property and equipment, net | 267 | 341 |
Operating lease assets | 385 | 4,359 |
Investment in unconsolidated affiliates | 1,065 | 1,935 |
Intangibles, net | 355 | 509 |
Other long-term assets | 2,177 | 824 |
Total assets | 16,082 | 14,827 |
Liabilities and Stockholders’ Deficit | ||
Accounts payable | 6,570 | 8,126 |
Accrued expense and other current liabilities | 8,987 | 14,326 |
Contract liability | 541 | 313 |
Note payable | 1,500 | 3,000 |
Loans payable, current | 0 | 12,025 |
Total current liabilities | 17,598 | 37,790 |
Loans payable, long-term | 425 | 0 |
Operating lease liabilities, long-term | 158 | 4,650 |
Warrant liability | 748 | 115 |
Total liabilities | 18,929 | 42,555 |
Commitments and contingencies | ||
Preferred stock,$0.001 par value; 1,000,000 shares authorized; zero issued | 0 | 0 |
Common stock, $0.001 par value; 100,000,000 shares authorized; 99,502,416 and 51,055,159 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively | 100 | 51 |
Additional paid-in-capital | 351,529 | 319,275 |
Accumulated other comprehensive income | 176 | (227) |
Accumulated deficit | (354,652) | (346,827) |
Total stockholders’ deficit | (2,847) | (27,728) |
Total liabilities and stockholders’ deficit | $ 16,082 | $ 14,827 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Sep. 30, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | |
Preferred stock, shares authorized (shares) | 1,000,000 | |
Preferred stock, shares issued (shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (shares) | 99,502,416 | 51,055,159 |
Common stock, shares outstanding (in shares) | 99,502,416 | 51,055,159 |
Unaudited Condensed Consolidate
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Income Statement [Abstract] | ||||
Revenue | $ 2,646 | $ 686 | $ 5,376 | $ 4,760 |
Cost and expense | ||||
Cost of revenue (excluding depreciation and amortization) | 1,679 | 189 | 2,910 | 3,323 |
Sales and marketing | 417 | 736 | 1,319 | 2,282 |
Technology and development | 738 | 752 | 2,863 | 2,910 |
General and administrative | 2,380 | 3,052 | 7,018 | 8,483 |
Depreciation and amortization | 72 | 229 | 228 | 814 |
Impairments | 463 | 0 | 463 | 0 |
Other operating expense | 0 | 0 | 0 | 6 |
Total cost and expense | 5,749 | 4,958 | 14,801 | 17,818 |
Operating loss | (3,103) | (4,272) | (9,425) | (13,058) |
Other income (expense) | ||||
Interest expense | (60) | (457) | (1,296) | (1,397) |
Other income, net | (58) | (24) | (1) | 23 |
Change in fair value of warrant liability | 5,570 | (160) | (633) | 502 |
Gain on lease termination | 2,044 | 0 | 3,582 | 0 |
Other loss, net | 21 | (28) | (52) | (27) |
Total other income (expense), net | 7,517 | (669) | 1,600 | (899) |
Income (loss) from continuing operations | 4,414 | (4,941) | (7,825) | (13,957) |
Loss from discontinued operations, net of tax | 0 | 0 | 0 | (2,610) |
Net income (loss) | 4,414 | (4,941) | (7,825) | (16,567) |
Other comprehensive income (loss) | ||||
Foreign currency translation adjustments | 65 | (289) | 403 | (256) |
Comprehensive income (loss) | $ 4,479 | $ (5,230) | $ (7,422) | $ (16,823) |
Weighted-average shares outstanding, basic and diluted (in shares) | 99,450 | 46,282 | 80,903 | 43,085 |
Net loss per share, basic and diluted | ||||
Continuing operations (usd per share) | $ 0.04 | $ (0.11) | $ (0.10) | $ (0.32) |
Discontinued operations (usd per share) | 0 | 0 | 0 | (0.06) |
Consolidated (usd per share) | $ 0.04 | $ (0.11) | $ (0.10) | $ (0.38) |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Stockholders Deficit - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit |
Beginning balance (in shares) at Dec. 31, 2018 | 39,053,312 | ||||
Beginning balance at Dec. 31, 2018 | $ (13,124) | $ 39 | $ 308,018 | $ 32 | $ (321,213) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net loss | (16,567) | (16,567) | |||
Share-based compensation | 379 | 379 | |||
Common stock sales (in shares) | 9,374,597 | ||||
Common stock issued | 9,340 | $ 9 | 9,331 | ||
Equity instrument exercises (in shares) | 2,250 | ||||
Equity instrument exercises | 4 | 4 | |||
Other | (256) | (256) | |||
Ending balance (in shares) at Sep. 30, 2019 | 48,430,159 | ||||
Ending balance at Sep. 30, 2019 | (20,224) | $ 48 | 317,732 | (224) | (337,780) |
Beginning balance (in shares) at Jun. 30, 2019 | 46,130,159 | ||||
Beginning balance at Jun. 30, 2019 | (16,899) | $ 46 | 315,829 | 65 | (332,839) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net loss | (4,941) | (4,941) | |||
Share-based compensation | 65 | 65 | |||
Common stock sales (in shares) | 2,300,000 | ||||
Common stock issued | 1,840 | $ 2 | 1,838 | ||
Other | (289) | (289) | |||
Ending balance (in shares) at Sep. 30, 2019 | 48,430,159 | ||||
Ending balance at Sep. 30, 2019 | $ (20,224) | $ 48 | 317,732 | (224) | (337,780) |
Beginning balance (in shares) at Dec. 31, 2019 | 51,055,159 | 51,055,159 | |||
Beginning balance at Dec. 31, 2019 | $ (27,728) | $ 51 | 319,275 | (227) | (346,827) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net loss | (7,825) | (7,825) | |||
Share-based compensation | 131 | 131 | |||
Common stock sales (in shares) | 48,298,893 | ||||
Common stock issued | 32,030 | $ 48 | 31,982 | ||
Equity instrument exercises (in shares) | 148,364 | ||||
Equity instrument exercises | 142 | $ 1 | 141 | ||
Other | $ 403 | 403 | |||
Ending balance (in shares) at Sep. 30, 2020 | 99,502,416 | 99,502,416 | |||
Ending balance at Sep. 30, 2020 | $ (2,847) | $ 100 | 351,529 | 176 | (354,652) |
Beginning balance (in shares) at Jun. 30, 2020 | 99,408,916 | ||||
Beginning balance at Jun. 30, 2020 | (7,439) | $ 99 | 351,417 | 111 | (359,066) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net loss | 4,414 | 4,414 | |||
Share-based compensation | 38 | 38 | |||
Common stock issued | 0 | ||||
Equity instrument exercises (in shares) | 93,500 | ||||
Equity instrument exercises | 75 | $ 1 | 74 | ||
Other | $ 65 | 65 | |||
Ending balance (in shares) at Sep. 30, 2020 | 99,502,416 | 99,502,416 | |||
Ending balance at Sep. 30, 2020 | $ (2,847) | $ 100 | $ 351,529 | $ 176 | $ (354,652) |
Unaudited Condensed Consolida_2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2020 | Sep. 30, 2019 | |
Statement of Cash Flows [Abstract] | ||
Net cash used in continuing operating activities | $ (14,532) | $ (10,748) |
Net cash used in discontinued operating activities | 0 | (7,159) |
Net cash used in operating activities | (14,532) | (17,907) |
Cash flows from investing activities: | ||
Proceeds from sale of business | 0 | 30,000 |
Purchases of property, equipment and software | (171) | (5) |
Payment of payroll costs capitalized to software in progress | 0 | (127) |
Advance to unrelated entity | (1,410) | 0 |
Net cash (used in) provided by continuing investing activities | (1,581) | 29,868 |
Net cash used in discontinued investing activities | 0 | (18,396) |
Net cash (used in) provided by investing activities | (1,581) | 11,472 |
Cash flows from financing activities: | ||
Proceeds from issuance of common stock, net | 32,147 | 9,344 |
Proceeds from debt issuance | 425 | 0 |
Payment of loan fees and debt issuance cost | 0 | (2,275) |
Repayments of debt | (13,781) | (25,526) |
Payment of contingent consideration in business acquisitions | (860) | 0 |
Net cash provided by (used in) financing activities | 17,931 | (18,457) |
Net change in cash, cash equivalents and restricted cash | 1,818 | (24,892) |
Cash, cash equivalents and restricted cash: | ||
Beginning of period, including cash in disposal group | 272 | 25,548 |
End of period | 2,090 | 656 |
Supplemental cash flow information: | ||
Cash paid for interest | 965 | 2,211 |
Supplemental schedule of non-cash investing and financing activities: | ||
Capitalization of interest to debt principal | 256 | 555 |
Increase in loan payable | 0 | 1,103 |
Settlement of operating lease liability through offset with operating lease asset of terminated office lease | $ 3,805 | $ 0 |
ORGANIZATION AND BUSINESS
ORGANIZATION AND BUSINESS | 9 Months Ended |
Sep. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BUSINESS | NOTE 1. ORGANIZATION AND BUSINESS Organization and Business Remark Holdings, Inc. and subsidiaries (“Remark”, “we”, “us”, or “our”), which include its consolidated variable-interest entities (“VIEs”), are primarily technology-focused. Our KanKan data intelligence platform serves as the basis for our development and deployment of artificial-intelligence-based (“AI-based”) solutions for businesses in many industries and geographies. We also own and operate an e-commerce digital media property focused on a luxury beach lifestyle. Our common stock is listed on the Nasdaq Capital Market under the ticker symbol MARK. We recognize revenue primarily from sales in the U.S. and China of AI-based products and services from our KanKan business. Economic and political risks Our operations in China are subject to special considerations and significant risks not typically associated with companies in North America, including risks associated with, among others, the political, economic and legal environment and foreign currency exchange. Our results may be adversely affected by changes in the political conditions in China, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation. COVID-19 Our unaudited condensed consolidated interim financial statements for the three and nine months ended September 30, 2020 were impacted by the effects of the global outbreak of a novel strain of coronavirus, or COVID-19, as national and local governmental authorities in China and the U.S., where we operate, have placed significant restrictions on travel and other activities within their respective countries, leading to extended business closures. The restrictions and resulting business closures have limited our operational capabilities, which could have a material adverse impact on our business and which have created significant uncertainties, such as the potential adverse effect of the pandemic on the economy, our vendors, our employees and customers and customer sentiment in general. The extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including the duration and severity of the outbreak, the length of the travel restrictions and business closures imposed by domestic and foreign governments, the impact on capital and financial markets and the related impact on the financial circumstances of our customers, all of which are highly uncertain and cannot be predicted. The pandemic-related situation is changing rapidly, and additional impacts of which we are not currently aware may arise, as recently underscored by the surge in cases in the U.S. We are closely monitoring developments in the U.S. and in China and are continually assessing the potential impact on our business. To mitigate the potential material negative effects that COVID-19 may have on our business and to do our part to provide customers with the means to limit the spread of COVID-19, we have repurposed and improved our existing urban life cycle solution that we were selling to make schools in China “smart” schools to build a new product line of high-quality, highly-effective thermal imaging solutions that leverage our innovative software to provide customers with the ability to scan crowds and areas of high foot traffic for indications that certain persons may require secondary screening. We have begun sales efforts primarily in the U.S., as well as in other countries. Going Concern During the nine months ended September 30, 2020, and in each fiscal year since our inception, we have incurred net losses which have resulted in an accumulated deficit of $354.7 million as of September 30, 2020. Additionally, our operations have historically used more cash than they have provided. Net cash used in continuing operating activities was $14.5 million during the nine months ended September 30, 2020. As of September 30, 2020, our cash and cash equivalents balance was $2.1 million, and we had a negative working capital balance of $5.8 million. On March 3, 2020, we entered into a common stock purchase agreement, later amended on April 9, 2020 (as amended, the “2020 Aspire Purchase Agreement”), with Aspire Capital Fund, LLC (“Aspire Capital”) under which Aspire Capital purchased $30.0 million of shares of our common stock. The 2020 Aspire Purchase Agreement, which we describe in more detail in Note 15 , terminated and replaced the common stock purchase agreement we had entered into with Aspire Capital on March 29, 2019 (the “2019 Aspire Purchase Agreement”). Concurrently with entering into the 2020 Aspire Purchase Agreement, we also entered into a registration rights agreement with Aspire Capital, in which we agreed to file with the Securities and Exchange Commission (the “SEC”) one or more registration statements, as necessary, and to the extent permissible and subject to certain exceptions, to register under the Securities Act of 1933, as amended, the sale of the shares of our common stock that may be issued to Aspire Capital under the 2020 Aspire Purchase Agreement. We have filed with the SEC a prospectus supplement to our effective shelf Registration Statement on Form S-3 (File No. 333-225448) registering all of the shares of common stock that may be offered to Aspire Capital from time to time under the 2020 Aspire Purchase Agreement. During the nine months ended September 30, 2020, we issued a total of 48,238,893 shares of our common stock to Aspire Capital under the 2019 Aspire Purchase Agreement and the 2020 Aspire Purchase Agreement in exchange for approximately $32.0 million plus Aspire Capital’s commitment to participate in the 2020 Aspire Purchase Agreement. Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities give rise to substantial doubt regarding our ability to continue as a going concern. We intend to fund our future operations and meet our financial obligations through revenue growth from our AI offerings, as well as through sales of our thermal-imaging products. We cannot, however, provide assurance that revenue, income and cash flows generated from our businesses will be sufficient to sustain our operations in the twelve months following the filing of this Form 10-Q. As a result, we are actively evaluating strategic alternatives including debt and equity financings and potential sales of investment assets or operating businesses. Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, in response to the COVID-19 pandemic), will play primary roles in determining whether we can successfully obtain additional capital. We cannot be certain that we will be successful at raising additional capital. A variety of factors, many of which are outside of our control, affect our cash flow; those factors include the effects of the COVID-19 pandemic, regulatory issues, competition, financial markets and other general business conditions. Based on financial projections, we believe that we will be able to meet our ongoing requirements for at least the next 12 months with existing cash, cash equivalents and cash resources, and based on the probable success of one or more of the following plans: • develop and grow new product line(s) • monetize existing assets • obtain additional capital through debt and/or equity issuances. However, projections are inherently uncertain and the success of our plans is largely outside of our control. As a result, there is substantial doubt regarding our ability to continue as a going concern, and we may fully utilize our cash resources prior to November 23, 2021. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of September 30, 2020, with the audited Consolidated Balance Sheet amounts as of December 31, 2019 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading. Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period. Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated Statement of Stockholders’ Deficit, each as of September 30, 2020, as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K (the “2019 Form 10-K”). Consolidation We include all of our subsidiaries, including the VIEs for which we are the primary beneficiary, in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation. To comply with China’s laws which restrict foreign ownership of entities that operate within industries deemed sensitive by the Chinese government, we employ what we believe is a commonly-used organizational structure consisting of a wholly-foreign owned enterprise (“WFOE”) and the VIEs to operate our KanKan business. We own 100% of the equity of the WFOE, while the VIEs are companies formed in China under local laws which are owned by members of our management team. We funded the registered capital and operating expenses of the VIEs by extending loans to the VIEs’ owners. We are the primary beneficiary of the VIEs because the relationships between the VIEs and our WFOE are governed by contractual agreements, including in each case an Exclusive Call Option Agreement, an Exclusive Business Cooperation Agreement, a Proxy Agreement and an Equity Pledge Agreement, which give us control over the operations of the VIEs. We use the fair value method to account for equity investments in which we cannot exercise significant influence over the investee, such as with our investment in Sharecare, Inc. (“Sharecare”). With regard to our investment in Sharecare, GAAP allows us to continue to carry our investment at cost less impairment until such time as an observable price change in the underlying security occurs. Any gains or losses resulting from a change in fair value are recorded to the statement of operations. We use the equity method for equity investments in which we can exercise significant influence over the investee (see Note 6 for information on our investments in unconsolidated affiliates). Use of Estimates We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, intangible assets, the useful lives of property and equipment, share-based compensation, the fair value of the warrant liability, deferred income taxes, inventory reserve and purchase price allocation, among other items. As of September 30, 2020, the impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods. Cash and cash equivalents Our cash and cash equivalents consist of funds held in bank accounts. Cash equivalents are highly-liquid investments with original maturities of three months or less, including money market funds. We maintain cash balances in United States dollars (“USD”), Chinese Renminbi (“RMB”), and Hong Kong dollars (“HKD”). The following table, reported in USD, disaggregates our cash balances by currency denomination (in thousands): September 30, 2020 December 31, 2019 Cash denominated in: USD $ 1,054 $ 216 HKD 712 2 RMB 324 54 Total cash $ 2,090 $ 272 We maintain substantially all of our USD-denominated cash at a U.S financial institution where the balances are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, however, our cash balances may exceed the FDIC-insured limit. As of September 30, 2020, we do not believe we have any significant concentrations of credit risk, although approximately $0.8 million of our USD-denominated cash balance exceeded the FDIC-insured limit. Cash held by our non-U.S. subsidiaries is subject to foreign currency fluctuations against the USD, although such risk is somewhat mitigated because we transfer U.S. funds to China to fund local operations. If, however, the USD is devalued significantly against the RMB, our cost to further develop our business in China could exceed original estimates. Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (an exit price). When reporting the fair values of our financial instruments, we prioritize those fair value measurements into one of three levels based on the nature of the inputs, as follows: Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities; Level 2: Valuations based on observable inputs that do not meet the criteria for Level 1, including quoted prices in inactive markets and observable market data for similar, but not identical instruments; and Level 3: Valuations based on unobservable inputs, which are based upon the best available information when external market data is limited or unavailable. The fair value hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not be available. We believe the reported carrying amounts for cash and cash equivalents, receivables, prepaids and other current assets, accounts payable, accrued expenses and other current liabilities, approximate their fair values because of the short-term nature of these financial instruments. Foreign Currency Translation We report all currency amounts in USD. Our China VIEs, however, maintain their books and records in their functional currency, which is RMB. In general, when consolidating our subsidiaries or VIEs with non-USD functional currencies, we translate the amounts of assets and liabilities into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit. We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted: 2020 2019 Exchange rates at September 30th: RMB:USD 0.147 0.140 HKD:USD 0.129 0.128 Average exchange rate during the nine months ended September 30th: RMB:USD 0.143 0.146 Revenue Recognition AI-Based Products We generate revenue by developing AI-based products, including fully-integrated AI solutions which combine our proprietary technology with third-party hardware and software products to meet end-user specifications. Under one type of contract for our AI-based products, we provide a single, continuous service to clients who control the assets as we create them. Accordingly, we recognize the revenue over the period of time during which we provide the service. Under another type of contract, we have performance obligations to provide fully-integrated AI solutions to our customer and we recognize revenue at the point in time when each performance obligation is completed and delivered to, tested by and accepted by our customer. We recognize revenue when we transfer control of the promised goods or services to our customers, and we recognize an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. If there is uncertainty related to the timing of collections from our customer, which may be the case if our customer is not the ultimate end user of our goods, we consider this to be uncertainty of the customer’s ability and intention to pay us when consideration is due. Accordingly, we recognize revenue only when we have transferred control of the goods or services and consideration received from the customer is nonrefundable. When customers pay us prior to when we satisfy our obligation to transfer control of promised goods or services, we record the amount that reflects the consideration to which we expect to be entitled as a contract liability until such time as we satisfy our performance obligation. For our contracts with customers, we generally extend short-term credit policies to our customers, typically up to one year for large-scale projects. We record the incremental costs of obtaining contracts as an expense when incurred, because such costs would otherwise be amortized over a period of less than one year if capitalized. Other We generate revenue from other sources, such as from e-commerce activity in which we sell goods to our customers, or media production which involves the production of video or Internet-based content for our customers. We recognize the revenue from these contracts at the point in time when we transfer control of the good sold to the customer or when we deliver the promised media content. Substantially all of our contracts with customers that generate Other revenue are completed within one year or less. Inventory We use the first-in first-out method to determine the cost of our inventory, then we report inventory at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated sales forecasts. Net Loss per Share We calculate basic net loss per share using the weighted-average number of common stock shares outstanding during the period. For the calculation of diluted net loss per share, we give effect to all the shares of common stock that were outstanding during the period plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is anti-dilutive. Dilutive potential shares of common stock consist of incremental shares of common stock issuable upon exercise of stock options and warrants. For the three and nine months ended September 30, 2020 and 2019, there were no reconciling items related to either the numerator or denominator of the loss per share calculation, as their effect would have been anti-dilutive. Securities which would have been anti-dilutive to a calculation of diluted earnings per share for the three and nine months ended September 30, 2020 and 2019 include 10,123,215 and 11,469,732 outstanding stock options, respectively, and 40,000 and 3,848,423 outstanding stock warrants, respectively. Segments As a result of our disposal of the previously-reported Travel and Entertainment segment, we currently report one segment: our Technology & Data Intelligence segment, which provides services to our customers based upon the data collected and processed by our proprietary data intelligence software. We have identified our Chief Executive Officer as our chief operating decision maker, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information about our products and services, our major customers, and the countries in which we hold material assets and in which we report revenue. All our material operating units qualify for aggregation due to their similar customer bases and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since we operate in one segment, all required financial information can be found in the accompanying financial statements. Liabilities Related to Warrants Issued We record certain common stock warrants we issued (see Note 4 for more detailed information) at fair value and recognize the change in the fair value of such warrants as a gain or loss which we report in the Other income (expense) section in our consolidated statement of operations. We report the warrants that we record at fair value as liabilities because they contain a conditional promise to issue a variable number of our common stock shares upon the warrants’ expiration, and the monetary amount of such obligation was fixed at the inception of the contract. We estimate the fair value of the warrants using an option pricing model. Recently Issued Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06 (“ASU 2020-06”), Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity . The ASU will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The ASU also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. With regard to our financial reporting, ASU 2020-06 will be effective January 1, 2024, and early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. We are currently evaluating what effect(s) the adoption of ASU 2020-06 may have on our consolidated financial statements, but we do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326) . The ASU requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, which may result in the earlier recognition of allowances for losses. With regard to our financial reporting, ASU 2016-13 will be effective beginning January 1, 2023, and early adoption is permitted. We do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. We have reviewed all accounting pronouncements recently issued by the FASB and the Securities and Exchange Commission. The authoritative pronouncements that we have already adopted did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, and except as otherwise noted above, we do not believe that any of the authoritative pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof. |
REVENUE
REVENUE | 9 Months Ended |
Sep. 30, 2020 | |
Revenue from Contract with Customer [Abstract] | |
REVENUE | NOTE 3. REVENUE We sell AI-based products that include our Remark AI Thermal Kits, rPads and Thermal Helmets in the U.S., as well as the various customized products we sell in China based upon facial recognition, gesture recognition and other technologies. We do not include disclosures related to remaining performance obligations because substantially all our contracts with customers have an original expected duration of one year or less or, with regard to our stand-ready obligations, the amounts involved are not material. Disaggregation of Revenue The following table presents a disaggregation of our revenue by major category (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 AI-based products $ 2,496 $ 549 $ 4,873 $ 3,439 Other 150 137 503 1,321 Revenue $ 2,646 $ 686 $ 5,376 $ 4,760 The following table presents a disaggregation of our revenue by country (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 China $ 2,051 $ 552 $ 3,383 $ 4,319 United States 590 134 1,852 441 Other countries 5 — 141 — Revenue $ 2,646 $ 686 $ 5,376 $ 4,760 Significant Judgments When accounting for revenue we make certain judgments, such as whether we act as a principal or as an agent in transactions or whether our contracts with customers fall within the scope of current GAAP regarding revenue, that affect the determination of the amount and timing of our revenue from contracts with customers. Based on the current facts and circumstances related to our contracts with customers, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted in terms of their potential impact on the amount and timing of our revenue. Contract Assets and Contract Liabilities We do not currently generate material contract assets. During the nine months ended September 30, 2020, our contract liability changed only as a result of routine business activity. During the nine months ended September 30, 2020, we recognized approximately $0.2 million of revenue which was included in the beginning balance of Contract liability at January 1, 2020, while during the comparable period of 2019, we did not recognize a material amount of revenue which was included in the beginning balance of Contract liability at January 1, 2019. During the nine months ended September 30, 2020 and 2019, we did not recognize revenue from performance obligations within the scope of ASC 606 that were satisfied in previous periods. Certain Agreements Related to AI-Based Product Sales In December 2018, we completed two fully-integrated AI solutions for which we fully performed under the agreement and title to the product passed to our customer, so we recognized cost of revenue of $4.0 million; however, we did not recognize the $4.6 million of revenue from such projects due to uncertainty regarding the timing of collection of amounts payable to us under the agreement. The uncertainty regarding the timing of collection prevented us from determining that collectibility of all amounts payable to us under the agreements was probable, resulting in a timing difference between recognition of cost and recognition of revenue. Though we cannot recognize the revenue until collectibility is deemed probable, we expect to fully collect the amounts payable to us under our legally-enforceable agreements and, therefore, we recorded a receivable of $4.6 million in Prepaid expense and other current assets, and a liability in Accrued expense and other current liabilities on our 2018 Consolidated Balance Sheet. |
FAIR VALUE MEASUREMENTS OF CERT
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES | 9 Months Ended |
Sep. 30, 2020 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES | NOTE 4. FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES Liabilities Related to Warrants to Purchase Common Stock At the end of each reporting period, until expiry, we use an option pricing model to estimate and report the fair value of liabilities related to certain outstanding warrants to purchase common stock. As of September 30, 2020, our outstanding liability-classified warrants include the warrants we issued or that we are obligated to issue as part of the consideration for our acquisition (the “CBG Acquisition”) of assets of China Branding Group Limited (“CBG”) in September 2016 (the “CBG Acquisition Warrants”). The warrants we issued in connection with the financing we obtained for the CBG Acquisition (referred to in our prior reports as the CBG Financing Warrants) expired on September 24, 2020 without being exercised; therefore, the balance of $0.7 million as of September 30, 2020 represents the liability associated with the CBG Acquisition Warrants. The following table presents the quantitative inputs, which we classify in Level 3 of the fair value hierarchy, used in estimating the fair value of the CBG Acquisition Warrants: September 30, 2020 December 31, 2019 Expected volatility 85.00 % 75.00 % Risk-free interest rate 0.16 % 1.65 % Expected remaining term (years) 2.98 3.72 The following table presents the change in the liability balance associated with our liability-classified warrants (in thousands): Nine Months Ended September 30, Year Ended December 31, 2020 2019 Balance at beginning of period $ 115 $ 1,383 Increase (decrease) in fair value 633 (1,268) Balance at end of period $ 748 $ 115 As of September 30, 2020 and 2019, warrants outstanding included CBG Acquisition Warrants which may be exercised to purchase 40,000 shares of our common stock at a per-share exercise price of $10.00 (we are also committed to the future issuance of additional CBG Acquisition Warrants to purchase up to 5,710,000 of the Company’s common shares at the same per-share exercise price as the CBG Acquisition Warrant that has already been issued) and, as of September 30, 2019, the CBG Financing Warrants, which could have been exercised to purchase 3,808,423 shares of our common stock at an exercise price of $3.86 per share. Contingent Consideration Issued in Business Acquisition Through December 31, 2019, we used the discounted cash flow valuation technique to estimate the fair value of the liability related to certain cash payments that we were obligated make related to our acquisition of Vegas.com, LLC (“Vegas.com”) in September 2015 that were contingent upon the performance of Vegas.com in the years ended December 31, 2016, 2017, and 2018 (the “Earnout Payments”). The significant unobservable inputs that we used, which we classify in Level 3 of the fair value hierarchy, were projected earnings before interest, taxes, depreciation and amortization (“EBITDA”), the probability of achieving certain amounts of EBITDA, and the rate used to discount the liability. On August 19, 2020, we paid all amounts that had remained outstanding related to the Earnout Payments and extinguished this liability. The following table presents the change during the nine months ended September 30, 2020 and the year ended December 31, 2019 in the balance of the liability associated with the Earnout Payments (in thousands): Nine Months Ended September 30, Year Ended December 31, 2020 2019 Balance at beginning of period $ 1,086 $ 990 Payments (1,132) (8) Change in fair value of contingent consideration — 10 Interest accrued on unpaid balance 46 94 Balance at end of period $ — $ 1,086 |
TRADE ACCOUNTS RECEIVABLE
TRADE ACCOUNTS RECEIVABLE | 9 Months Ended |
Sep. 30, 2020 | |
Receivables [Abstract] | |
TRADE ACCOUNTS RECEIVABLE | NOTE 5. TRADE ACCOUNTS RECEIVABLE September 30, 2020 December 31, 2019 Gross accounts receivable balance $ 5,114 $ 4,171 Allowance for bad debt (2,264) (2,207) Accounts receivable, net $ 2,850 $ 1,964 Generally, it is not unusual for Chinese entities to pay their vendors on longer timelines than the timelines typically observed in U.S. commerce. Trade receivables related to our China-based AI projects (exclusive of certain financial technology (“FinTech”) services we provided) represent 63% of our gross trade receivables. |
INVESTMENT IN UNCONSOLIDATED AF
INVESTMENT IN UNCONSOLIDATED AFFILIATES | 9 Months Ended |
Sep. 30, 2020 | |
Noncontrolling Interest [Abstract] | |
INVESTMENT IN UNCONSOLIDATED AFFILIATES | NOTE 6. INVESTMENT IN UNCONSOLIDATED AFFILIATES In 2009, we co-founded a U.S.-based venture, Sharecare, to build a web-based platform that simplifies the search for health and wellness information. The other co-founders of Sharecare were Dr. Mehmet Oz, HARPO Productions, Discovery Communications, Jeff Arnold and Sony Pictures Television. As of September 30, 2020 and December 31, 2019, we owned approximately 4.4% of Sharecare’s issued stock, the value of which was $1.0 million, and maintained representation on its Board of Directors. During June 2018, one of our consolidated VIEs acquired a 20% interest in Beijing All-in-one Cloud Net Technology, Co. Ltd. (“AIO”), a Chinese technology company which provided consulting and data services to the Chinese film industry, in exchange for $1.0 million, a portion of which was paid as of September 30, 2020, and a license to use our proprietary KanKan data intelligence platform in China. Based on additional information we obtained during the third quarter of 2020, we determined that the COVID-19 outbreak in China had permanently ended AIO’s ability to conduct its business and we wrote off our remaining investment of $0.9 million in that entity, which, when netted against the remaining $0.5 million we owed to AIO for the equity interest, resulted in a loss on impairment of $0.4 million. |
PREPAID EXPENSE AND OTHER CURRE
PREPAID EXPENSE AND OTHER CURRENT ASSETS | 9 Months Ended |
Sep. 30, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
PREPAID EXPENSE AND OTHER CURRENT ASSETS | NOTE 7. PREPAID EXPENSE AND OTHER CURRENT ASSETS The following table presents the components of prepaid expense and other current assets (in thousands): September 30, 2020 December 31, 2019 Other receivables $ 3,387 $ 3,712 Prepaid expense 2,207 633 Deposits 53 7 Other current assets 184 271 Total $ 5,831 $ 4,623 |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 9 Months Ended |
Sep. 30, 2020 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | NOTE 8. PROPERTY AND EQUIPMENT Property and equipment consist of the following (in thousands, except estimated lives): Estimated Life September 30, 2020 December 31, 2019 Computers and equipment 3 1,020 989 Furniture and fixtures 3 46 23 Software 3 4,940 4,896 Leasehold improvements 3 139 114 Total property, equipment and software $ 6,145 $ 6,022 Less accumulated depreciation (5,878) (5,681) Total property, equipment and software, net $ 267 $ 341 For the nine months ended September 30, 2020 and 2019, depreciation (and amortization of software) expense was $0.2 million and $0.6 million, respectively. |
LEASES
LEASES | 9 Months Ended |
Sep. 30, 2020 | |
Leases [Abstract] | |
LEASES | NOTE 9. LEASES We lease office space and a vehicle under contracts we classify as operating leases. None of our leases are financing leases. The following table presents the detail of our lease expense, net of sublease income, which is reported in General and administrative expense (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating lease expense $ 72 $ 492 $ 544 $ 1,195 Short-term lease expense 54 67 159 231 Less: Sublease income — (94) — (172) Lease expense $ 126 $ 465 $ 703 $ 1,254 We reported within continuing operating cash flows for the nine months ended September 30, 2020 and 2019, $0.2 million and $1.5 million, respectively, of cash paid for amounts included in the measurement of operating lease liabilities. As of September 30, 2020, our operating leases had a weighted-average remaining lease term of approximately 22 months, and we used a weighted-average discount rate of approximately 13% to measure our operating lease liabilities. As of December 31, 2019 we reported right of use assets of $4.4 million and lease liabilities of $7.5 million. During August 2020, we entered into a settlement agreement relating to the lease for our former office space in Las Vegas which we vacated during March 2020. During the nine months ended September 30, 2020, we reduced right of use assets and operating lease liabilities relating to this lease by $3.8 million and $5.3 million, respectively, which resulted in a gain on lease termination of $1.5 million. In addition, we recognized a further gain of $2.0 million during August 2020, when we entered into a settlement with our former landlord, which is described in more detail in Note 9 . As of September 30, 2020, our right of use assets were $0.4 million and our remaining lease obligations were $0.5 million. Maturity of Lease Liabilities The following table presents information regarding the maturities of our undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our September 30, 2020 unaudited Condensed Consolidated Balance Sheet (in thousands): Operating lease liabilities maturing during the next: One year $ 343 Two years 122 Three years 50 Total undiscounted cash flows $ 515 Present value of cash flows $ 466 Lease liabilities on balance sheet: Short-term $ 308 Long-term 158 Total lease liabilities $ 466 Termination of Lease and Related Landlord Actions Beginning approximately July 2019, we were not able to pay our obligations under the office lease for our former office located at 3960 Howard Hughes Parkway in Las Vegas, Nevada. On March 5, 2020, our former landlord, BRE/HC Las Vegas Property Holdings, L.L.C (the “Hughes Center Landlord”), exercised its right to terminate the lease as of such date as a result of the ongoing payment default. On April 9, 2020, the Hughes Center Landlord filed suit against us in Nevada to recover the approximately $1.1 million of rent owed through March 5, 2020, plus damages resulting from the early termination of the lease. On August 3, 2020, we entered into a settlement agreement with the Hughes Center Landlord (the “Hughes Center Lease Settlement”), pursuant to which we immediately paid $0.45 million to the Hughes Center Landlord and agreed to pay another $0.15 million in three equal installments on each of September 1, 2020, October 1, 2020 and November 1, 2020 (an aggregate payment of $0.6 million), in full settlement of our obligations with respect to such office lease. As of December 31, 2019, we had accrued approximately $2.3 million for settlement of this matter. During the period ended September 30, 2020, we accrued an additional $0.3 million related to this matter. See Note 1 8 for additional information regarding the Hughes Center Lease Settlement and the Hughes Center Landlord’s legal actions against us. Other In September 2020, we prepaid the lease expense for a short-term lease on a property in the Los Angeles, California area. The $0.3 million we paid remained in the balance of Prepaid expense and other current assets as of September 30, 2020. Significant Judgments When accounting for our leases, we make certain judgments, such as whether a contract contains a lease or what discount rate to use, that affect the determination of the amount of our lease assets and liabilities. Based on the current facts and circumstances related to our contracts, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted. |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 9 Months Ended |
Sep. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | NOTE 10. INTANGIBLE ASSETS The following table summarizes intangible assets by category (in thousands): September 30, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (929) $ 327 $ 1,256 $ (874) $ 382 Other intangible assets — — — 68 (68) — $ 1,256 $ (929) $ 327 $ 1,324 $ (942) $ 382 Indefinite-lived intangible assets License to operate in China 28 28 127 127 Total intangible assets $ 1,284 $ 355 $ 1,451 $ 509 Total amortization expense was de minimis and $0.3 million for the nine months ended September 30, 2020 and 2019, respectively. |
OTHER LONG-TERM ASSETS
OTHER LONG-TERM ASSETS | 9 Months Ended |
Sep. 30, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
OTHER LONG-TERM ASSETS | NOTE 11. OTHER LONG-TERM ASSETS Included in Other long-term assets as of September 30, 2020 is an advance of $1.5 million we made to an unrelated entity (our “China Business Partner”) pursuant to an agreement we entered into with the China Business Partner. We are in the process of negotiating a separate contract with the China Business Partner setting out the terms pursuant to which the China |
ACCRUED EXPENSE AND OTHER CURRE
ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES | 9 Months Ended |
Sep. 30, 2020 | |
Other Liabilities Disclosure [Abstract] | |
ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES | NOTE 12. ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES The following table presents the components of Accrued expense and other current liabilities (in thousands): September 30, 2020 December 31, 2019 Accrued compensation and benefit-related expense $ 1,195 $ 1,210 Accrued interest 439 302 Other accrued expense 369 1,037 Other payables 3,339 3,780 Operating lease liability - current 308 2,877 Other current liabilities 3,337 5,120 Total $ 8,987 $ 14,326 |
DEBT
DEBT | 9 Months Ended |
Sep. 30, 2020 | |
Debt Disclosure [Abstract] | |
DEBT | NOTE 13. DEBT Short-Term Debt On April 12, 2017, we issued a short-term note payable in the principal amount of $3.0 million to a private lender in exchange for cash in the same amount. The agreement, which does not have a stated interest rate, required us to repay the note plus a fee of $115 thousand on the maturity date of June 30, 2017. The note is accruing interest at $500 per day on the unpaid principal until we repay the note in full. As of December 31, 2019, we owed $3.0 million in principal and $0.3 million in accrued interest. During the nine months ended September 30, 2020, we repaid $1.5 million of the principal, meaning that as of September 30, 2020, we owed $1.5 million in principal and $0.4 million in accrued interest. Other Debt The following table presents debt (in thousands) as of: September 30, 2020 December 31, 2019 MGG loan due May 2020 $ — $ 12,025 Loans payable, current — 12,025 PPP loan due April 2022 425 — Loans payable, long-term $ 425 $ — Loan due May 2020 We were a party to a financing agreement dated as of September 24, 2015 (as amended, the “Financing Agreement”) with certain of our subsidiaries as borrowers (together with Remark, the “Borrowers”), certain of our subsidiaries as guarantors, the lenders from time to time party thereto (the “Lenders”) and MGG Investment Group LP, in its capacity as collateral agent and administrative agent for the Lenders (“MGG”), pursuant to which the Lenders extended credit to the Borrowers consisting of a term loan in the aggregate principal amount of $35.5 million (the “MGG Loan”). On May 15, 2019, we completed the sale of all of the issued and outstanding membership interests of Vegas.com (the “VDC Transaction”) and used the cash proceeds of $30 million to pay amounts due under the Financing Agreement, of which approximately $10 million remained outstanding after giving effect to the application of such cash proceeds. On May 28, 2020, we repaid in full all outstanding obligations under, and terminated, the Financing Agreement. Loan due April 2022 On April 15, 2020, we entered into a loan agreement (the “PPP Loan”) with our bank under the U.S. Small Business Administration’s Paycheck Protection Program. Under the PPP Loan, we borrowed $0.4 million with a stated interest rate of one percent for a term of two years from the initial disbursement date of April 15, 2020. The PPP Loan is eligible for forgiveness as part of the CARES Act if certain requirements are met. We continue to evaluate and monitor the requirements of the CARES Act that allow for forgiveness. The accrued interest expense relating these loans for three and nine months ended September 30, 2020 was not material. As of September 30, 2020, the SBA loan had an outstanding principal balance of $0.4 million included in loans payable. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 14. COMMITMENTS AND CONTINGENCIES At September 30, 2020, we had no material commitments outside the normal course of business. Contingencies As of September 30, 2020, we were neither a defendant in any material pending legal proceeding nor are we aware of any material threatened claims against us and, therefore, we have not accrued any contingent liabilities. On February 21, 2018, we initiated a legal proceeding (the “CBG Litigation”) against CBG, Adam Roseman, and CBG’s Joint Official Liquidators (the “JOLs”) arising from the CBG Acquisition. The CBG Litigation was filed in the United States District Court for the District of Nevada and is captioned as Remark Holdings, Inc., et al. v. China Branding Group, Limited (In Official Liquidation), et al. , Case No. 2:18-cv-00322. In the CBG Litigation, we sought a declaration from the court that we are entitled to rescission of the purchase agreement relating to the CBG Acquisition and all transactions related to the CBG Acquisition, a declaration that such purchase agreement and the transactions consummated pursuant thereto be rescinded and void ab initio, a declaration that we are not required to deliver the remaining CBG Acquisition Warrants allowing for the purchase of 5,710,000 shares of common stock at a per-share exercise price of $10.00, an order directing release to us of any consideration held in escrow in connection with the CBG Acquisition, and disgorgement of all consideration paid by us in connection with the CBG Acquisition. We alleged that the defendants fraudulently mispresented and concealed material information regarding the companies we acquired in the CBG Acquisition. We entered into a settlement agreement with Mr. Roseman to settle all claims against him, and we dismissed those claims on May 13, 2019. We entered into a Stipulation for Settlement dated January 15, 2019 with CBG and the JOLs, which sets forth the binding terms of their settlement agreement (the “Stipulation for Settlement”). Pursuant to the Stipulation for Settlement, we will issue fully-transferable warrants on a non-diluted basis allowing for the purchase of 5,710,000 shares of our common stock at a per-share exercise price of $6.00, which warrants are exercisable for a period of 5 years from the date of the Stipulation for Settlement, and which we have the right to cause the warrant holders to exercise if the closing price of our common stock is $8.00 or greater on any 5 non-consecutive days in any consecutive 30-day trading window. The parties to the Stipulation for Settlement also agreed to negotiate anti-dilution provisions for the warrants. In exchange for the foregoing |
STOCKHOLDERS' EQUITY, SHARE-BAS
STOCKHOLDERS' EQUITY, SHARE-BASED COMPENSATION AND NET LOSS PER SHARE | 9 Months Ended |
Sep. 30, 2020 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE | NOTE 15. STOCKHOLDERS' EQUITY, SHARE-BASED COMPENSATION AND NET LOSS PER SHARE Common Shares Authorized Our Amended and Restated Certificate of Incorporation authorizes us to issue up to 100,000,000 shares of our common stock, of which 99,505,041 shares were outstanding as of November 20, 2020. In addition, as of November 20, 2020, we had outstanding stock options allowing for the purchase of as many as approximately 15.7 million shares of common stock and we had outstanding warrants to purchase 40,000 shares of common stock. If all of our outstanding stock options and warrants were exercised, the total number of shares of our common stock that we would be required to issue would greatly exceed the number of our remaining authorized but unissued shares of common stock. As a result of such potential shortfall in the number of our authorized shares of common stock, we will have insufficient shares of common stock available to issue in connection with the exercise of our outstanding stock options and warrants or any future equity financing transaction we may seek to undertake. Accordingly, we intend to seek approval of an increase in the number of our authorized shares of common stock at a 2020 special meeting of stockholders. Equity Issuances On March 3, 2020, we entered into the 2020 Aspire Purchase Agreement with Aspire Capital which provided that, upon the terms and subject to the conditions and limitations set forth therein, we had the right to direct Aspire Capital to purchase up to an aggregate of $30.0 million of shares of our common stock over the 30-month term of the 2020 Aspire Purchase Agreement. The 2020 Aspire Purchase Agreement replaced the 2019 Aspire Purchase Agreement, which terminated under the terms of the 2020 Aspire Purchase Agreement. In consideration for entering into the 2020 Aspire Purchase Agreement, we issued to Aspire Capital 2,374,545 shares of our common stock. As of September 30, 2020, we have issued to Aspire Capital a total of 44,227,890 shares of our common stock under the 2020 Aspire Purchase Agreement. During the nine months ended September 30, 2020, we issued a total of 48,238,893 shares of our common stock to Aspire Capital under the 2019 Aspire Purchase Agreement and the 2020 Aspire Purchase Agreement in exchange for $32.0 million plus Aspire Capital’s commitment to participate in the 2020 Aspire Purchase Agreement. Share-Based Compensation We are authorized to issue equity-based awards under our 2010 Equity Incentive Plan, our 2014 Incentive Plan, and our 2017 Incentive Plan, each of which our stockholders have approved. We also award cash bonuses (“China Cash Bonuses”) to our employees in China, which grants are not subject to a formal incentive plan and which can only be settled in cash. We grant such awards to attract, retain and motivate eligible officers, directors, employees and consultants. Under each of the plans, we have granted shares of restricted stock and options to purchase common stock to our officers and employees with exercise prices equal to or greater than the fair value of the underlying shares on the grant date. Stock options and China Cash Bonuses generally expire 10 years from the grant date. All forms of equity awards and China Cash Bonuses vest upon the passage of time, the attainment of performance criteria, or both. When participants exercise stock options, we issue any shares of our common stock resulting from such exercise from new authorized and unallocated shares available at the time of exercise. The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of September 30, 2020, and changes during the nine months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 10,359,079 $ 4.20 Exercised (148,364) 0.87 Forfeited, cancelled or expired (87,500) 2.63 Outstanding at September 30, 2020 10,123,215 $ 4.26 5.9 $ — Options exercisable at September 30, 2020 9,959,528 $ 4.32 5.9 $ — The following table summarizes activity under our equity incentive plans related to the China Cash Bonuses as of September 30, 2020, and changes during the nine months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 1,087,500 $ 5.20 Granted 300,000 1.37 Forfeited, cancelled or expired (313,500) 5.44 Outstanding at September 30, 2020 1,074,000 $ 4.07 6.6 $ — Options exercisable at September 30, 2020 752,250 $ 5.21 5.2 $ — During the three months ended September 30, 2020, we granted to employees and directors, excluding our CEO, options to purchase approximately 5.6 million shares of our common stock. The option agreements governing the grants contain a stipulation that, regardless of vesting, such options do not become exercisable unless and until stockholders approve an amendment to our Amended and Restated Certificate of Incorporation to increase in the number of authorized shares of our common stock in an amount sufficient to allow for the exercise of the options and we have filed a corresponding Certificate of Amendment to our Amended and Restated Certificate of Incorporation reflecting such increase in the number of authorized shares of our common stock. Given the requirement for stockholder approval of additional authorized shares to make the stock options exercisable, a grant date for accounting purposes has not yet occurred. During the three months ended September 30, 2020 and 2019, we incurred share-based compensation expense (benefit) of $(0.4) million and $0.1 million, respectively. During the nine months ended September 30, 2020 and 2019, we incurred share-based compensation expense of $0.3 million and $0.3 million, respectively. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2020 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 16. RELATED PARTY TRANSACTIONS On July 27, 2020, we collected approximately $0.5 million of receivables from related parties. The receivables represented cash advances in excess of expense reimbursements to senior management. The cash received from these receivables was subsequently injected as additional capital into our VIEs in China. |
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS | 9 Months Ended |
Sep. 30, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
DISCONTINUED OPERATIONS | NOTE 17. DISCONTINUED OPERATIONS On May 15, 2019, we completed the VDC Transaction for an aggregate purchase price of $30.0 million. The business we sold in the VDC Transaction formerly comprised our Travel and Entertainment segment. The following table presents the major classes of line items constituting the pretax profit or loss of the disposed Travel and Entertainment segment (in thousands): Nine Months Ended September 30, 2019 Revenue $ 27,432 Cost of revenue (excluding depreciation and amortization) 4,016 Selling, general and administrative 18,383 Technology and development 3,280 Depreciation, amortization and impairments 8,007 Other operating expense 384 Other expense (income) and loss (gain), net (3,814) Loss from discontinued operations before income taxes (2,824) Benefit from income taxes 214 Loss from discontinued operations $ (2,610) |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2020 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 18. SUBSEQUENT EVENTS On each of September 1, 2020, October 1, 2020 and November 1, 2020, we paid a cumulative total of $150,000 to the Hughes Center Landlord representing, in addition to the $0.45 million we initially paid under the Hughes Center Lease Settlement in August 2020, full settlement of our obligations with respect to the office lease for our former office located at 3960 Howard Hughes Parkway in Las Vegas, Nevada. On November 5, 2020, the Hughes Center Landlord filed a Notice of Voluntary Dismissal with Prejudice with the District Court of Clark County, Nevada dismissing their legal action against us. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Basis of Accounting | We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of September 30, 2020, with the audited Consolidated Balance Sheet amounts as of December 31, 2019 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading. Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period. Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated Statement of Stockholders’ Deficit, each as of September 30, 2020, as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K (the “2019 Form 10-K”). |
Consolidation | Consolidation We include all of our subsidiaries, including the VIEs for which we are the primary beneficiary, in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation. To comply with China’s laws which restrict foreign ownership of entities that operate within industries deemed sensitive by the Chinese government, we employ what we believe is a commonly-used organizational structure consisting of a wholly-foreign owned enterprise (“WFOE”) and the VIEs to operate our KanKan business. We own 100% of the equity of the WFOE, while the VIEs are companies formed in China under local laws which are owned by members of our management team. We funded the registered capital and operating expenses of the VIEs by extending loans to the VIEs’ owners. We are the primary beneficiary of the VIEs because the relationships between the VIEs and our WFOE are governed by contractual agreements, including in each case an Exclusive Call Option Agreement, an Exclusive Business Cooperation Agreement, a Proxy Agreement and an Equity Pledge Agreement, which give us control over the operations of the VIEs. |
Use of Estimates | Use of Estimates We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, intangible assets, the useful lives of property and equipment, share-based compensation, the fair value of the warrant liability, deferred income taxes, inventory reserve and purchase price allocation, among other items. As of September 30, 2020, the impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods. |
Cash and cash equivalents | Cash and cash equivalents Our cash and cash equivalents consist of funds held in bank accounts. Cash equivalents are highly-liquid investments with original maturities of three months or less, including money market funds. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (an exit price). When reporting the fair values of our financial instruments, we prioritize those fair value measurements into one of three levels based on the nature of the inputs, as follows: Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities; Level 2: Valuations based on observable inputs that do not meet the criteria for Level 1, including quoted prices in inactive markets and observable market data for similar, but not identical instruments; and Level 3: Valuations based on unobservable inputs, which are based upon the best available information when external market data is limited or unavailable. The fair value hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not be available. We believe the reported carrying amounts for cash and cash equivalents, receivables, prepaids and other current assets, accounts payable, accrued expenses and other current liabilities, approximate their fair values because of the short-term nature of these financial instruments. |
Foreign Currency Translation | Foreign Currency Translation We report all currency amounts in USD. Our China VIEs, however, maintain their books and records in their functional currency, which is RMB. In general, when consolidating our subsidiaries or VIEs with non-USD functional currencies, we translate the amounts of assets and liabilities into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit. |
Revenue Recognition | Revenue Recognition AI-Based Products We generate revenue by developing AI-based products, including fully-integrated AI solutions which combine our proprietary technology with third-party hardware and software products to meet end-user specifications. Under one type of contract for our AI-based products, we provide a single, continuous service to clients who control the assets as we create them. Accordingly, we recognize the revenue over the period of time during which we provide the service. Under another type of contract, we have performance obligations to provide fully-integrated AI solutions to our customer and we recognize revenue at the point in time when each performance obligation is completed and delivered to, tested by and accepted by our customer. We recognize revenue when we transfer control of the promised goods or services to our customers, and we recognize an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. If there is uncertainty related to the timing of collections from our customer, which may be the case if our customer is not the ultimate end user of our goods, we consider this to be uncertainty of the customer’s ability and intention to pay us when consideration is due. Accordingly, we recognize revenue only when we have transferred control of the goods or services and consideration received from the customer is nonrefundable. When customers pay us prior to when we satisfy our obligation to transfer control of promised goods or services, we record the amount that reflects the consideration to which we expect to be entitled as a contract liability until such time as we satisfy our performance obligation. For our contracts with customers, we generally extend short-term credit policies to our customers, typically up to one year for large-scale projects. We record the incremental costs of obtaining contracts as an expense when incurred, because such costs would otherwise be amortized over a period of less than one year if capitalized. Other We generate revenue from other sources, such as from e-commerce activity in which we sell goods to our customers, or media production which involves the production of video or Internet-based content for our customers. We recognize the revenue from these contracts at the point in time when we transfer control of the good sold to the customer or when we deliver the promised media content. Substantially all of our contracts with customers that generate Other revenue are completed within one year or less. |
Inventory | Inventory We use the first-in first-out method to determine the cost of our inventory, then we report inventory at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated sales forecasts. |
Net Loss per Share | Net Loss per Share We calculate basic net loss per share using the weighted-average number of common stock shares outstanding during the period. For the calculation of diluted net loss per share, we give effect to all the shares of common stock that were outstanding during the period plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is anti-dilutive. Dilutive potential shares of common stock consist of incremental shares of common stock issuable upon exercise of stock options and warrants. |
Segments | Segments As a result of our disposal of the previously-reported Travel and Entertainment segment, we currently report one segment: our Technology & Data Intelligence segment, which provides services to our customers based upon the data collected and processed by our proprietary data intelligence software. We have identified our Chief Executive Officer as our chief operating decision maker, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information about our products and services, our major customers, and the countries in which we hold material assets and in which we report revenue. All our material operating units qualify for aggregation due to their similar customer bases and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since we operate in one segment, all required financial information can be found in the accompanying financial statements. |
Liabilities Related to Warrants Issued | Liabilities Related to Warrants Issued We record certain common stock warrants we issued (see Note 4 for more detailed information) at fair value and recognize the change in the fair value of such warrants as a gain or loss which we report in the Other income (expense) section in our consolidated statement of operations. We report the warrants that we record at fair value as liabilities because they contain a conditional promise to issue a variable number of our common stock shares upon the warrants’ expiration, and the monetary amount of such obligation was fixed at the inception of the contract. We estimate the fair value of the warrants using an option pricing model. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06 (“ASU 2020-06”), Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity . The ASU will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The ASU also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. With regard to our financial reporting, ASU 2020-06 will be effective January 1, 2024, and early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. We are currently evaluating what effect(s) the adoption of ASU 2020-06 may have on our consolidated financial statements, but we do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326) . The ASU requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, which may result in the earlier recognition of allowances for losses. With regard to our financial reporting, ASU 2016-13 will be effective beginning January 1, 2023, and early adoption is permitted. We do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. We have reviewed all accounting pronouncements recently issued by the FASB and the Securities and Exchange Commission. The authoritative pronouncements that we have already adopted did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, and except as otherwise noted above, we do not believe that any of the authoritative pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Schedule of Cash and Cash Equivalents | We maintain cash balances in United States dollars (“USD”), Chinese Renminbi (“RMB”), and Hong Kong dollars (“HKD”). The following table, reported in USD, disaggregates our cash balances by currency denomination (in thousands): September 30, 2020 December 31, 2019 Cash denominated in: USD $ 1,054 $ 216 HKD 712 2 RMB 324 54 Total cash $ 2,090 $ 272 |
Schedule of Exchange Rates | We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted: 2020 2019 Exchange rates at September 30th: RMB:USD 0.147 0.140 HKD:USD 0.129 0.128 Average exchange rate during the nine months ended September 30th: RMB:USD 0.143 0.146 |
REVENUE (Tables)
REVENUE (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue by Major Category | The following table presents a disaggregation of our revenue by major category (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 AI-based products $ 2,496 $ 549 $ 4,873 $ 3,439 Other 150 137 503 1,321 Revenue $ 2,646 $ 686 $ 5,376 $ 4,760 |
Schedule of Disaggregation of Revenue by Country | The following table presents a disaggregation of our revenue by country (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 China $ 2,051 $ 552 $ 3,383 $ 4,319 United States 590 134 1,852 441 Other countries 5 — 141 — Revenue $ 2,646 $ 686 $ 5,376 $ 4,760 |
FAIR VALUE MEASUREMENTS OF CE_2
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Fair Value Disclosures [Abstract] | |
Schedule of quantitative inputs | The following table presents the quantitative inputs, which we classify in Level 3 of the fair value hierarchy, used in estimating the fair value of the CBG Acquisition Warrants: September 30, 2020 December 31, 2019 Expected volatility 85.00 % 75.00 % Risk-free interest rate 0.16 % 1.65 % Expected remaining term (years) 2.98 3.72 |
Reconciliation of liabilities of warrants | The following table presents the change in the liability balance associated with our liability-classified warrants (in thousands): Nine Months Ended September 30, Year Ended December 31, 2020 2019 Balance at beginning of period $ 115 $ 1,383 Increase (decrease) in fair value 633 (1,268) Balance at end of period $ 748 $ 115 |
Reconciliation of earnout payments | The following table presents the change during the nine months ended September 30, 2020 and the year ended December 31, 2019 in the balance of the liability associated with the Earnout Payments (in thousands): Nine Months Ended September 30, Year Ended December 31, 2020 2019 Balance at beginning of period $ 1,086 $ 990 Payments (1,132) (8) Change in fair value of contingent consideration — 10 Interest accrued on unpaid balance 46 94 Balance at end of period $ — $ 1,086 |
TRADE ACCOUNTS RECEIVABLE (Tabl
TRADE ACCOUNTS RECEIVABLE (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Receivables [Abstract] | |
Schedule of components of prepaid expense and other current assets | September 30, 2020 December 31, 2019 Gross accounts receivable balance $ 5,114 $ 4,171 Allowance for bad debt (2,264) (2,207) Accounts receivable, net $ 2,850 $ 1,964 |
PREPAID EXPENSE AND OTHER CUR_2
PREPAID EXPENSE AND OTHER CURRENT ASSETS (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Prepaid expense and other current assets | The following table presents the components of prepaid expense and other current assets (in thousands): September 30, 2020 December 31, 2019 Other receivables $ 3,387 $ 3,712 Prepaid expense 2,207 633 Deposits 53 7 Other current assets 184 271 Total $ 5,831 $ 4,623 |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Property, Plant and Equipment [Abstract] | |
Schedule of property and equipment | Property and equipment consist of the following (in thousands, except estimated lives): Estimated Life September 30, 2020 December 31, 2019 Computers and equipment 3 1,020 989 Furniture and fixtures 3 46 23 Software 3 4,940 4,896 Leasehold improvements 3 139 114 Total property, equipment and software $ 6,145 $ 6,022 Less accumulated depreciation (5,878) (5,681) Total property, equipment and software, net $ 267 $ 341 |
LEASES (Tables)
LEASES (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Leases [Abstract] | |
Schedule of lease expense, net of sublease income | The following table presents the detail of our lease expense, net of sublease income, which is reported in General and administrative expense (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Operating lease expense $ 72 $ 492 $ 544 $ 1,195 Short-term lease expense 54 67 159 231 Less: Sublease income — (94) — (172) Lease expense $ 126 $ 465 $ 703 $ 1,254 |
Schedule of maturity of lease liabilities | The following table presents information regarding the maturities of our undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our September 30, 2020 unaudited Condensed Consolidated Balance Sheet (in thousands): Operating lease liabilities maturing during the next: One year $ 343 Two years 122 Three years 50 Total undiscounted cash flows $ 515 Present value of cash flows $ 466 Lease liabilities on balance sheet: Short-term $ 308 Long-term 158 Total lease liabilities $ 466 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of finite-lived intangible assets | The following table summarizes intangible assets by category (in thousands): September 30, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (929) $ 327 $ 1,256 $ (874) $ 382 Other intangible assets — — — 68 (68) — $ 1,256 $ (929) $ 327 $ 1,324 $ (942) $ 382 Indefinite-lived intangible assets License to operate in China 28 28 127 127 Total intangible assets $ 1,284 $ 355 $ 1,451 $ 509 |
Schedule of indefinite-lived intangible assets | The following table summarizes intangible assets by category (in thousands): September 30, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (929) $ 327 $ 1,256 $ (874) $ 382 Other intangible assets — — — 68 (68) — $ 1,256 $ (929) $ 327 $ 1,324 $ (942) $ 382 Indefinite-lived intangible assets License to operate in China 28 28 127 127 Total intangible assets $ 1,284 $ 355 $ 1,451 $ 509 |
ACCRUED EXPENSE AND OTHER CUR_2
ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Other Liabilities Disclosure [Abstract] | |
Schedule of accrued expense and other current liabilities | The following table presents the components of Accrued expense and other current liabilities (in thousands): September 30, 2020 December 31, 2019 Accrued compensation and benefit-related expense $ 1,195 $ 1,210 Accrued interest 439 302 Other accrued expense 369 1,037 Other payables 3,339 3,780 Operating lease liability - current 308 2,877 Other current liabilities 3,337 5,120 Total $ 8,987 $ 14,326 |
DEBT (Tables)
DEBT (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of long-term debt instruments | The following table presents debt (in thousands) as of: September 30, 2020 December 31, 2019 MGG loan due May 2020 $ — $ 12,025 Loans payable, current — 12,025 PPP loan due April 2022 425 — Loans payable, long-term $ 425 $ — |
STOCKHOLDERS' EQUITY, STOCK-BAS
STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Stockholders' Equity Note [Abstract] | |
Schedule of stock option activity under equity incentive plans | The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of September 30, 2020, and changes during the nine months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 10,359,079 $ 4.20 Exercised (148,364) 0.87 Forfeited, cancelled or expired (87,500) 2.63 Outstanding at September 30, 2020 10,123,215 $ 4.26 5.9 $ — Options exercisable at September 30, 2020 9,959,528 $ 4.32 5.9 $ — The following table summarizes activity under our equity incentive plans related to the China Cash Bonuses as of September 30, 2020, and changes during the nine months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 1,087,500 $ 5.20 Granted 300,000 1.37 Forfeited, cancelled or expired (313,500) 5.44 Outstanding at September 30, 2020 1,074,000 $ 4.07 6.6 $ — Options exercisable at September 30, 2020 752,250 $ 5.21 5.2 $ — |
DISCONTINUED OPERATIONS (Tables
DISCONTINUED OPERATIONS (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Schedule of disposal groups by major classes of line items | The following table presents the major classes of line items constituting the pretax profit or loss of the disposed Travel and Entertainment segment (in thousands): Nine Months Ended September 30, 2019 Revenue $ 27,432 Cost of revenue (excluding depreciation and amortization) 4,016 Selling, general and administrative 18,383 Technology and development 3,280 Depreciation, amortization and impairments 8,007 Other operating expense 384 Other expense (income) and loss (gain), net (3,814) Loss from discontinued operations before income taxes (2,824) Benefit from income taxes 214 Loss from discontinued operations $ (2,610) |
ORGANIZATION AND BUSINESS (Deta
ORGANIZATION AND BUSINESS (Details) - USD ($) $ in Thousands | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Mar. 03, 2020 | Dec. 31, 2019 | |
Debt Instrument [Line Items] | ||||
Accumulated deficit | $ 354,652 | $ 346,827 | ||
Net cash used in operating activities | 14,532 | $ 10,748 | ||
Cash and cash equivalents | 2,090 | $ 272 | ||
Working capital | $ 5,800 | |||
Aspire Capital Fund, LLC | ||||
Debt Instrument [Line Items] | ||||
Number of shares issued (in shares) | 48,238,893 | |||
Consideration received on sale of stock | $ 32,000 | |||
Private Placement | Aspire Capital Fund, LLC | ||||
Debt Instrument [Line Items] | ||||
Purchase amount of shares authorized | $ 30,000 | |||
Number of shares issued (in shares) | 44,227,890 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and cash equivalents (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Total cash | $ 2,090 | $ 272 |
USD | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Total cash | 1,054 | 216 |
HKD | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Total cash | 712 | 2 |
RMB | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Total cash | $ 324 | $ 54 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020USD ($)shares | Sep. 30, 2019shares | Sep. 30, 2020USD ($)segmentshares | Sep. 30, 2019shares | |
Disaggregation of Revenue [Line Items] | ||||
Cash in excess of FDIC-insured limit | $ | $ 0.8 | $ 0.8 | ||
Term of contract | 1 year | |||
Number of reportable segments | segment | 1 | |||
Stock options | ||||
Disaggregation of Revenue [Line Items] | ||||
Anti-dilutive securities (in shares) | 10,123,215 | 11,469,732 | 10,123,215 | 11,469,732 |
Warrant | ||||
Disaggregation of Revenue [Line Items] | ||||
Anti-dilutive securities (in shares) | 40,000 | 3,848,423 | 40,000 | 3,848,423 |
Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Performance period | 1 year |
SUMMARY OF SIGNIFICANT ACCOUN_6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Foreign Currency Translation (Details) | Sep. 30, 2020 | Sep. 30, 2019 |
RMB | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Exchange rate | 0.147 | 0.140 |
HKD | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Exchange rate | 0.129 | 0.128 |
Weighted Average | ||
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items] | ||
Exchange rate | 0.143 | 0.146 |
REVENUE - Disaggregated by Majo
REVENUE - Disaggregated by Major Category (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||
Revenue | $ 2,646 | $ 686 | $ 5,376 | $ 4,760 |
AI-based products | ||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||
Revenue | 2,496 | 549 | 4,873 | 3,439 |
Other | ||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||||
Revenue | $ 150 | $ 137 | $ 503 | $ 1,321 |
REVENUE - Disaggregation by Cou
REVENUE - Disaggregation by Country (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 2,646 | $ 686 | $ 5,376 | $ 4,760 |
China | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 2,051 | 552 | 3,383 | 4,319 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 590 | 134 | 1,852 | 441 |
Other countries | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 5 | $ 0 | $ 141 | $ 0 |
REVENUE - Narrative (Details)
REVENUE - Narrative (Details) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Dec. 31, 2018USD ($)contract | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Dec. 31, 2019USD ($) | |
Disaggregation of Revenue [Line Items] | ||||||
Revenue recognized on liability balances | $ 200,000 | $ 0 | ||||
Revenue recognized from performance obligations satisfied in previous periods | 0 | 0 | ||||
Cost of revenue (excluding depreciation and amortization) | $ 1,679,000 | $ 189,000 | 2,910,000 | 3,323,000 | ||
Accounts receivable | 2,850,000 | 2,850,000 | $ 1,964,000 | |||
Revenue recognized on projects | 2,646,000 | $ 686,000 | 5,376,000 | $ 4,760,000 | ||
AI Solutions | ||||||
Disaggregation of Revenue [Line Items] | ||||||
Number of contracts | contract | 2 | |||||
Cost of revenue (excluding depreciation and amortization) | $ 4,000,000 | |||||
Accounts receivable | $ 4,600,000 | $ 3,200,000 | 3,200,000 | 3,400,000 | ||
Revenue recognized on projects | $ 200,000 | $ 1,100,000 |
FAIR VALUE MEASUREMENTS OF CE_3
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES - Quantitative Inputs (Details) - Warrant liabilities - Fair Value, Inputs, Level 3 | Sep. 30, 2020 | Dec. 31, 2019 |
Expected volatility | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrant liability, measurement input | 0.8500 | 0.7500 |
Risk-free interest rate | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrant liability, measurement input | 0.0016 | 0.0165 |
Expected remaining term (years) | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrant liability, measurement input | 2.98 | 3.72 |
FAIR VALUE MEASUREMENTS OF CE_4
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES - Narrative (Details) - $ / shares | Sep. 30, 2020 | Sep. 30, 2019 | Jan. 15, 2019 | Feb. 21, 2018 |
CBG Acquisition Warrants | ||||
Class of Warrant or Right [Line Items] | ||||
Warrants outstanding (in shares) | 40,000 | 40,000 | ||
Exercise price of warrants (usd per share) | $ 10 | $ 10 | $ 6 | $ 10 |
Warrants obligated to issue (in shares) | 5,710,000 | 5,710,000 | 5,710,000 | |
CBG Financing Warrants | ||||
Class of Warrant or Right [Line Items] | ||||
Warrants outstanding (in shares) | 3,808,423 | |||
Exercise price of warrants (usd per share) | $ 3.86 |
FAIR VALUE MEASUREMENTS OF CE_5
FAIR VALUE MEASUREMENTS OF CERTAIN LIABILITIES - Change in Fair Value of Warrants Accounted for as Derivative Liabilities (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Dec. 31, 2019 | |
Warrant liabilities | ||
Contingent Consideration | ||
Balance at beginning of period | $ 115 | $ 1,383 |
Increase (decrease) in fair value | 633 | (1,268) |
Balance at end of period | 748 | 115 |
Earnout payment liabilities | ||
Contingent Consideration | ||
Balance at beginning of period | 1,086 | 990 |
Payments | (1,132) | (8) |
Increase (decrease) in fair value | 0 | 10 |
Interest accrued on unpaid balance | 46 | 94 |
Balance at end of period | $ 0 | $ 1,086 |
TRADE ACCOUNTS RECEIVABLE (Deta
TRADE ACCOUNTS RECEIVABLE (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Gross accounts receivable balance | $ 5,114 | $ 4,171 |
Allowance for bad debt | (2,264) | (2,207) |
Accounts receivable, net | $ 2,850 | $ 1,964 |
AI-based products | Product Concentration Risk | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Percentage of gross trade receivables | 63.00% |
INVESTMENT IN UNCONSOLIDATED _2
INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) $ in Millions | 1 Months Ended | 3 Months Ended | |
Jun. 30, 2018USD ($)entity | Sep. 30, 2020USD ($) | Dec. 31, 2019USD ($) | |
Noncontrolling Interest [Line Items] | |||
Number of consolidated VIEs | entity | 1 | ||
All-in-one Cloud Net Technology, Co | |||
Noncontrolling Interest [Line Items] | |||
Interest in VIE acquired | 20.00% | ||
Noncontrolling interest | $ 1 | $ 0.9 | |
Equity interest owed | 0.5 | ||
Loss on impairment | 0.4 | ||
Sharecare | |||
Noncontrolling Interest [Line Items] | |||
Noncontrolling interest | $ 1 | $ 1 | |
Sharecare | Sharecare | |||
Noncontrolling Interest [Line Items] | |||
Ownership percentage in unconsolidated affiliate | 4.40% | 4.40% |
PREPAID EXPENSE AND OTHER CUR_3
PREPAID EXPENSE AND OTHER CURRENT ASSETS (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Prepaid Expense and Other Current Assets | ||
Other receivables | $ 3,387 | $ 3,712 |
Prepaid expense | 2,207 | 633 |
Deposits | 53 | 7 |
Other current assets | 184 | 271 |
Total | $ 5,831 | $ 4,623 |
PROPERTY AND EQUIPMENT (Details
PROPERTY AND EQUIPMENT (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Property, Plant and Equipment [Line Items] | |||
Total property, equipment and software | $ 6,145 | $ 6,022 | |
Less accumulated depreciation | (5,878) | (5,681) | |
Total property, equipment and software, net | 267 | 341 | |
Depreciation (and amortization of software) expense | $ 200 | $ 600 | |
Computers and equipment | |||
Property, Plant and Equipment [Line Items] | |||
Estimated Life (Years) | 3 years | ||
Total property, equipment and software | $ 1,020 | 989 | |
Furniture and fixtures | |||
Property, Plant and Equipment [Line Items] | |||
Estimated Life (Years) | 3 years | ||
Total property, equipment and software | $ 46 | 23 | |
Software | |||
Property, Plant and Equipment [Line Items] | |||
Estimated Life (Years) | 3 years | ||
Total property, equipment and software | $ 4,940 | 4,896 | |
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Estimated Life (Years) | 3 years | ||
Total property, equipment and software | $ 139 | $ 114 |
LEASES - Lease Expense (Details
LEASES - Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Leases [Abstract] | ||||
Operating lease expense | $ 72 | $ 492 | $ 544 | $ 1,195 |
Short-term lease expense | 54 | 67 | 159 | 231 |
Less: Sublease income | 0 | (94) | 0 | (172) |
Lease expense | $ 126 | $ 465 | $ 703 | $ 1,254 |
LEASES - Narrative (Details)
LEASES - Narrative (Details) $ in Thousands | Nov. 01, 2020USD ($) | Oct. 01, 2020USD ($) | Sep. 01, 2020USD ($) | Aug. 03, 2020USD ($)installment | Apr. 09, 2020USD ($) | Aug. 31, 2020USD ($) | Nov. 01, 2020USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Dec. 31, 2019USD ($) |
Lessee, Lease, Description [Line Items] | ||||||||||||
Cash paid for operating lease liabilities | $ 200 | $ 1,500 | ||||||||||
Weighted-average remaining lease term | 22 months | 22 months | ||||||||||
Weighted-average discount rate | 13.00% | 13.00% | ||||||||||
Right of use asset | $ 385 | $ 385 | $ 4,359 | |||||||||
Lease liability | 466 | 466 | 7,500 | |||||||||
Gain on lease termination | 2,044 | $ 0 | 3,582 | $ 0 | ||||||||
Damages sought | $ 1,100 | |||||||||||
Prepaid lease expense | 300 | 300 | ||||||||||
Office Space | ||||||||||||
Lessee, Lease, Description [Line Items] | ||||||||||||
Right of use asset | 400 | 400 | ||||||||||
Lease liability | 500 | 500 | ||||||||||
Operating lease assets | 3,800 | |||||||||||
Decrease in operating lease liabilities | 5,300 | |||||||||||
Gain on lease termination | $ 2,000 | 1,500 | ||||||||||
Hughes Center Lease Settlement | ||||||||||||
Lessee, Lease, Description [Line Items] | ||||||||||||
Payments for legal settlements | $ 150 | $ 450 | ||||||||||
Number of payment installments | installment | 3 | |||||||||||
Loss contingency accrual | $ 300 | $ 300 | $ 2,300 | |||||||||
Hughes Center Lease Settlement | Forecast | ||||||||||||
Lessee, Lease, Description [Line Items] | ||||||||||||
Payments for legal settlements | $ 150 | $ 150 | $ 600 |
LEASES - Maturity of Lease Liab
LEASES - Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Operating lease liabilities maturing during the next: | ||
One year | $ 343 | |
Two years | 122 | |
Three years | 50 | |
Total undiscounted cash flows | 515 | |
Present value of cash flows | 466 | $ 7,500 |
Lease liabilities on balance sheet: | ||
Short-term | 308 | 2,877 |
Long-term | 158 | 4,650 |
Present value of cash flows | $ 466 | $ 7,500 |
INTANGIBLE ASSETS (Details)
INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Finite-lived intangible assets | |||
Gross Amount | $ 1,256 | $ 1,324 | |
Accumulated Amortization | (929) | (942) | |
Net Amount | 327 | 382 | |
Total intangible assets | |||
Gross Amount | 1,284 | 1,451 | |
Net Amount | 355 | 509 | |
Amortization expense | 300 | $ 300 | |
License to operate in China | |||
Indefinite-lived intangible assets | |||
Indefinite lived intangible assets | 28 | 127 | |
Domain names | |||
Finite-lived intangible assets | |||
Gross Amount | 1,256 | 1,256 | |
Accumulated Amortization | (929) | (874) | |
Net Amount | 327 | 382 | |
Other intangible assets | |||
Finite-lived intangible assets | |||
Gross Amount | 0 | 68 | |
Accumulated Amortization | 0 | (68) | |
Net Amount | $ 0 | $ 0 |
OTHER LONG-TERM ASSETS (Details
OTHER LONG-TERM ASSETS (Details) $ in Millions | 9 Months Ended |
Sep. 30, 2020USD ($) | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Loan to unrelated entity | $ 1.5 |
Aggregate potential loan amount | $ 5.1 |
Loan receivable term | 5 years |
Interest rate on loan | 10.00% |
ACCRUED EXPENSE AND OTHER CUR_3
ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Other Liabilities Disclosure [Abstract] | ||
Accrued compensation and benefit-related expense | $ 1,195 | $ 1,210 |
Accrued interest | 439 | 302 |
Other accrued expense | 369 | 1,037 |
Other payables | 3,339 | 3,780 |
Operating lease liability - current | 308 | 2,877 |
Other current liabilities | 3,337 | 5,120 |
Total | $ 8,987 | $ 14,326 |
DEBT - Short-Term Debt Narrativ
DEBT - Short-Term Debt Narrative (Details) - USD ($) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | Apr. 12, 2017 | |
Short-term Debt [Line Items] | |||
Note payable | $ 1,500,000 | $ 3,000,000 | |
Principal owed | 1,500,000 | 3,000,000 | |
Accrued interest owed | 400,000 | $ 300,000 | |
Repayment of debt | $ 1,500,000 | ||
Short-term note payable to private lender | |||
Short-term Debt [Line Items] | |||
Note payable | $ 3,000,000 | ||
Fee payable in relation to short-term note payable | 115,000 | ||
Daily interest accrued on unpaid balance after maturity | $ 500 |
DEBT - Schedule of Debt Instrum
DEBT - Schedule of Debt Instruments (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Debt Instrument [Line Items] | ||
Loans payable, current | $ 0 | $ 12,025 |
Loans payable, long-term | 425 | 0 |
Loans Payable | ||
Debt Instrument [Line Items] | ||
Loans payable, long-term | 425 | 0 |
Loans Payable | ||
Debt Instrument [Line Items] | ||
Loans payable, current | $ 0 | $ 12,025 |
DEBT - Other Debt Narrative (De
DEBT - Other Debt Narrative (Details) - USD ($) | Apr. 15, 2020 | Sep. 30, 2020 | May 15, 2019 | Sep. 24, 2015 |
Loans Payable | ||||
Debt Instrument [Line Items] | ||||
Original principal amount | $ 35,500,000 | |||
Financing Agreement | Loans Payable | ||||
Debt Instrument [Line Items] | ||||
Debt outstanding | $ 10,000,000 | |||
Paycheck Protection Program, CARES Act | Loans Payable | ||||
Debt Instrument [Line Items] | ||||
Original principal amount | $ 400,000 | |||
Debt outstanding | $ 400,000 | |||
Debt interest rate percentage | 1.00% | |||
Term of debt | 2 years | |||
Discontinued Operations, Disposed of by Sale | Vegas.com LLC | ||||
Debt Instrument [Line Items] | ||||
Aggregate purchase price | $ 30,000,000 |
COMMITMENTS AND CONTINGENCIES -
COMMITMENTS AND CONTINGENCIES - Narrative (Details) - CBG Acquisition Warrants - $ / shares | Jan. 15, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Feb. 21, 2018 |
Class of Warrant or Right [Line Items] | ||||
Warrants that would have been issued to holders on as-exercised basis (shares) | 5,710,000 | 5,710,000 | 5,710,000 | |
Exercise price of warrants (usd per share) | $ 6 | $ 10 | $ 10 | $ 10 |
Warrant exercise term | 5 years | |||
Threshold minimum stock price trigger for exercise of warrants (usd per share) | $ 8 | |||
Threshold non-consecutive trading day window | 5 days | |||
Consecutive trading day window | 30 days |
STOCKHOLDERS' EQUITY, SHARE-B_2
STOCKHOLDERS' EQUITY, SHARE-BASED COMPENSATION AND NET LOSS PER SHARE - Narrative (Details) - USD ($) $ in Millions | Mar. 03, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Nov. 20, 2020 | Jun. 30, 2020 | Dec. 31, 2019 | Jun. 30, 2019 | Dec. 31, 2018 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | 100,000,000 | |||||||
Common stock, shares outstanding (in shares) | 99,502,416 | 99,502,416 | 51,055,159 | |||||||
Shares of common stock outstanding (in shares) | 10,359,079 | |||||||||
Shares granted in period (in shares) | 5,600,000 | |||||||||
Share-based compensation expense | $ (0.4) | $ 0.1 | $ 0.3 | $ 0.3 | ||||||
Subsequent Event | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, shares outstanding (in shares) | 99,505,041 | |||||||||
Warrants outstanding (in shares) | 40,000 | |||||||||
Common Stock | Subsequent Event | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares of common stock outstanding (in shares) | 15,700,000 | |||||||||
Common Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, shares outstanding (in shares) | 99,502,416 | 48,430,159 | 99,502,416 | 48,430,159 | 99,408,916 | 51,055,159 | 46,130,159 | 39,053,312 | ||
Option award expiration period | 10 years | |||||||||
Aspire Capital Fund, LLC | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Number of shares issued (in shares) | 48,238,893 | |||||||||
Consideration received on sale of stock | $ 32 | |||||||||
Aspire Capital Fund, LLC | Private Placement | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Purchase amount of shares authorized | $ 30 | |||||||||
Number of shares issued (in shares) | 2,374,545 | |||||||||
Number of shares issued (in shares) | 44,227,890 | |||||||||
Aspire Capital Fund, LLC | Private Placement | Common Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Period of purchase stock | 30 months |
STOCKHOLDERS' EQUITY, SHARE-B_3
STOCKHOLDERS' EQUITY, SHARE-BASED COMPENSATION AND NET LOSS PER SHARE - Stock Options Activity (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2020USD ($)$ / sharesshares | Sep. 30, 2020USD ($)$ / sharesshares | |
Shares | ||
Outstanding at beginning of period (in shares) | shares | 10,359,079 | |
Exercised (in shares) | shares | (148,364) | |
Granted (in shares) | shares | 5,600,000 | |
Forfeited, cancelled or expired (in shares) | shares | (87,500) | |
Options exercisable (in shares) | shares | 9,959,528 | 9,959,528 |
Weighted-Average Exercise Price | ||
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 4.20 | |
Exercised (in dollars per share) | $ / shares | 0.87 | |
Forfeited, cancelled or expired (in dollars per share) | $ / shares | 2.63 | |
Outstanding at end of period (in dollars per share) | $ / shares | $ 4.26 | 4.26 |
Options exercisable (in dollars per share) | $ / shares | $ 4.32 | $ 4.32 |
Weighted-Average Remaining Contractual Term (in years) | ||
Outstanding (term) | 5 years 10 months 24 days | |
Options exercisable (term) | 5 years 10 months 24 days | |
Aggregate Intrinsic Value (in thousands) | ||
Outstanding | $ | $ 0 | $ 0 |
Options exercisable | $ | $ 0 | $ 0 |
China Cash Bonus Awards | ||
Shares | ||
Outstanding at beginning of period (in shares) | shares | 1,087,500 | |
Granted (in shares) | shares | 300,000 | |
Forfeited, cancelled or expired (in shares) | shares | (313,500) | |
Outstanding at end of period (in shares) | shares | 1,074,000 | 1,074,000 |
Options exercisable (in shares) | shares | 752,250 | 752,250 |
Weighted-Average Exercise Price | ||
Outstanding at beginning of period (in dollars per share) | $ / shares | $ 5.20 | |
Granted (in dollars per share) | $ / shares | 1.37 | |
Forfeited, cancelled or expired (in dollars per share) | $ / shares | 5.44 | |
Outstanding at end of period (in dollars per share) | $ / shares | $ 4.07 | 4.07 |
Options exercisable (in dollars per share) | $ / shares | $ 5.21 | $ 5.21 |
Weighted-Average Remaining Contractual Term (in years) | ||
Outstanding (term) | 6 years 7 months 6 days | |
Options exercisable (term) | 5 years 2 months 12 days | |
Aggregate Intrinsic Value (in thousands) | ||
Outstanding | $ | $ 0 | $ 0 |
Options exercisable | $ | $ 0 | $ 0 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) $ in Millions | Sep. 30, 2020USD ($) |
Management | Advances To Senior Management | |
Related Party Transaction [Line Items] | |
Receivables from related parties | $ 0.5 |
DISCONTINUED OPERATIONS (Detail
DISCONTINUED OPERATIONS (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | May 15, 2019 | |
Line items constituting pretax profit or loss | |||||
Loss from discontinued operations | $ 0 | $ 0 | $ 0 | $ (2,610) | |
Discontinued Operations, Disposed of by Sale | VDC Transaction | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Aggregate purchase price | $ 30,000 | ||||
Line items constituting pretax profit or loss | |||||
Revenue | 27,432 | ||||
Cost of revenue (excluding depreciation and amortization) | 4,016 | ||||
Selling, general and administrative | 18,383 | ||||
Technology and development | 3,280 | ||||
Depreciation, amortization and impairments | 8,007 | ||||
Other operating expense | 384 | ||||
Other expense (income) and loss (gain), net | (3,814) | ||||
Loss from discontinued operations before income taxes | (2,824) | ||||
Benefit from income taxes | 214 | ||||
Loss from discontinued operations | $ (2,610) |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - Hughes Center Lease Settlement - USD ($) $ in Thousands | Sep. 01, 2020 | Aug. 03, 2020 | Nov. 01, 2020 |
Subsequent Event [Line Items] | |||
Payments for legal settlements | $ 150 | $ 450 | |
Subsequent Event | |||
Subsequent Event [Line Items] | |||
Payments for legal settlements | $ 150 |